Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04122313 · ClinicalTrials.gov registry record

Post-contracture Release Radiation for Dupuytren's Disease

A clinical trial of Dupuytren Contracture and Dupuytren's Disease, sponsored by University of Minnesota.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT04122313: Recruiting study of Dupuytren Contracture and Dupuytren's Disease, sponsored by University of Minnesota.

NCT04122313 is a study of Dupuytren Contracture and Dupuytren's Disease that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 50 participants, below the 86-participant average among 4 other Dupuytren Contracture trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04122313, a study of Dupuytren Contracture and Dupuytren's Disease, is actively recruiting participants, sponsored by University of Minnesota.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

To determine if the clinical impression of clinicians, ie that patients are improving with the current treatment pathway for Dupuytren's (contracture release followed by radiation), can be substantiated with scientific evidence.

Primary Outcome

The primary study endpoint is the patient's self-reported function which will be assessed using the validated Southampton Dupuytren's Scoring System (SDSS) questionnaire. The SDSS is a 5 item questionnaire with item scores ranging from 0 (no problem) to 4 (severe problem). Total scores are a sum of the 5 item scores with a total score range of 0 to 20. High scores indicate greater impairment due to the disease.

Interventions

  • OTHER Evaluation of Dupuytren's Disease Treatment

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2019-05-31
Est. Completion 2029-03-01
University of Minnesota

966 total trials

What NCT04122313 shows while recruiting

NCT04122313 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 86-participant average among 4 other Dupuytren Contracture trials with a reported enrollment target (42% lower).

The record links to 10 conditions, with Dupuytren Contracture appearing as the primary indexed condition, and to 1 intervention - of which Evaluation of Dupuytren's Disease Treatment is the first listed.

NCT04122313 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT04122313 about?

NCT04122313 is a clinical study titled "Post-contracture Release Radiation for Dupuytren's Disease". To determine if the clinical impression of clinicians, ie that patients are improving with the current treatment pathway for Dupuytren's (contracture release followed by radiation), can be substantiated with scientific evidence.

What is the current status of trial NCT04122313?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2019-05-31. Estimated completion is 2029-03-01.

What conditions does trial NCT04122313 study?

This clinical trial studies the following conditions: Dupuytren Contracture, Dupuytren's Disease, Dupuytren Disease of Palm and Finger, Dupuytren Disease of Finger, Dupuytrens Contracture of Both Hands.

What interventions are being tested in trial NCT04122313?

The interventions under investigation include: Evaluation of Dupuytren's Disease Treatment (OTHER).

Who is sponsoring clinical trial NCT04122313?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04122313 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dupuytren Contracture

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04122313, the US trial registry maintained by the National Library of Medicine. NCT04122313 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.